§ EQUITY
USD

DMRA

DAMORA THERAPEUTICS INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
82 increased/new, 12 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Fidelity Management9.0M0.0%+3687%
Fairmount Funds Management LLC8.7M16.3%n/a
Avoro Capital Advisors LLC3.8M1.0%n/a
Venrock Adviser, LLC3.6M3.5%n/a
FCPM III SERVICES B.V.2.4M8.8%n/a
RA CAPITAL MANAGEMENT, L.P.2.4M0.7%n/a
◇ AC INTELLIGENCE

Top institutional owners for DMRA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER71.3% · 42 holders
QUALITY / COMPOUNDER19.3% · 3 holders
TACTICAL / MACRO7.2% · 4 holders
DEALER / BANK1.0% · 10 holders
PASSIVE / INDEX0.8% · 4 holders
SYSTEMATIC / QUANT0.3% · 2 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for DMRA in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention DMRA yet.